Nanotechnology‐based drug delivery systems for melanoma antitumoral therapy: a review
RB Rigon, MH Oyafuso, AT Fujimura… - BioMed research …, 2015 - Wiley Online Library
Melanoma (MEL) is a less common type of skin cancer, but it is more aggressive with a high
mortality rate. The World Cancer Research Fund International (GLOBOCAN 2012) estimates …
mortality rate. The World Cancer Research Fund International (GLOBOCAN 2012) estimates …
Options of therapeutics and novel delivery systems of drugs for the treatment of melanoma
Melanoma is one of the most severe cancerous diseases. The cells employ multiple
signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell …
signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell …
[HTML][HTML] Nanodelivery systems for cutaneous melanoma treatment
I Pereira, C Monteiro, M Pereira-Silva, D Peixoto… - European journal of …, 2023 - Elsevier
Cutaneous melanoma (CM) is a multifactorial disease whose treatment still presents
challenges: the rapid progression to advanced CM, which leads to frequent recurrences …
challenges: the rapid progression to advanced CM, which leads to frequent recurrences …
Nano-drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment
M Xu, S Li - Cancer Letters, 2023 - Elsevier
Melanoma, the most aggressive form of cutaneous malignancy arising from melanocytes, is
frequently characterized by metastasis. Despite considerable progress in melanoma …
frequently characterized by metastasis. Despite considerable progress in melanoma …
Nanomedicine: A pragmatic approach for tackling melanoma skin cancer
Melanoma is the most aggressive form of skin cancer and its annual incidence rates are
increasing globally. Though chemotherapy, radiotherapy, immunotherapy and targeted …
increasing globally. Though chemotherapy, radiotherapy, immunotherapy and targeted …
Recent advances in targeted nanoparticles drug delivery to melanoma
Melanoma is one of the most aggressive skin cancers, notorious for its high multidrug
resistance and low survival rate. Conventional therapies (eg, dacarbazine, interferon-alpha …
resistance and low survival rate. Conventional therapies (eg, dacarbazine, interferon-alpha …
Nanocarrier-based drug delivery for melanoma therapeutics
M Song, C Liu, S Chen, W Zhang - International Journal of Molecular …, 2021 - mdpi.com
Melanoma, as a tumor cell derived from melanocyte transformation, has the characteristics
of malignant proliferation, high metastasis, rapid recurrence, and a low survival rate …
of malignant proliferation, high metastasis, rapid recurrence, and a low survival rate …
Recent developments in nanomedicine for melanoma treatment
JQ Tang, XY Hou, CS Yang, YX Li, Y Xin… - … journal of cancer, 2017 - Wiley Online Library
Melanoma is a most aggressive skin cancer with limited therapeutic options and its
incidence is increasing rapidly in recent years. The discovery and application of new …
incidence is increasing rapidly in recent years. The discovery and application of new …
Drug Delivery Systems and Flavonoids: Current Knowledge in Melanoma Treatment and Future Perspectives
Melanoma is an aggressive form of skin cancer with a high prevalence in the population. An
early diagnosis is crucial to cure this disease. Still, when this is not possible, combining …
early diagnosis is crucial to cure this disease. Still, when this is not possible, combining …
Nanotechnology addressing cutaneous melanoma: The Italian landscape
L Battaglia, A Scomparin, C Dianzani, P Milla… - Pharmaceutics, 2021 - mdpi.com
Cutaneous melanoma is one of the most aggressive solid tumors, with a low survival for the
metastatic stage. Currently, clinical melanoma treatments include surgery, chemotherapy …
metastatic stage. Currently, clinical melanoma treatments include surgery, chemotherapy …